Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthNUTX -1.14%75 PS Ratio is 1.61 as of Aug. 28, 2026, which is 77% above its 10-year median of 0.91. GuruFocus rates NUTX with a GF Score™ of 75/100 and a GF Value™ of $82.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Nutex Health ranks worse than 51.36% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nutex Health's share price is $191.69.
Nutex Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $118.93. Hence, Nutex Health's PS Ratio for today is 1.61.
Warning Sign:
Nutex Health Inc stock PS Ratio (=1.63) is close to 3-year high of 1.74.
The historical rank and industry rank for Nutex Health's PS Ratio or its related term are showing as below:
NUTX'
s PS Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.91 Max: 19.91
Current: 1.62
During the past 7 years, Nutex Health's highest PS Ratio was 19.91. The lowest was 0.09. And the median was 0.91.
NUTX's PS Ratio is ranked worse than 51.36% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 1.535
vs NUTX: 1.62
Nutex Health Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Nutex Health was -5.30% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 35.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.10% per year.
During the past 7 years, Nutex Health's highest 3-Year average Revenue per Share Growth Rate was 35.70% per year. The lowest was -4.20% per year. And the median was 18.00% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Nutex Health PS Ratio Related Terms
Nutex Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Nutex Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nutex Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Nutex Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Nutex Health's PS Ratio for today is calculated as
Nutex Health's Share Price of today is $191.69. Nutex Health's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $118.93.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Nutex Health (NUTX) has a PS Ratio of 1.61 as of Aug. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nutex Health and its competitors. This is 77% above median its historical median of 0.91. Over the past decade, Nutex Health's PS Ratio has ranged from 0.09 to 19.91. According to the industry distribution chart, Nutex Health ranks #340 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is Nutex Health's PS Ratio too high?
Nutex Health's current PS Ratio of 1.61 is 77% above median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 19.91. The Healthcare Providers & Services industry median PS Ratio is 1.54. Nutex Health's value of 1.61 is 4.9% above this industry median. Based on the distribution chart, Nutex Health ranks #340 out of 662 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nutex Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's PS Ratio compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #340 out of 662 companies for PS Ratio. This places Nutex Health in the lower half of its industry. The industry median PS Ratio is 1.54. Nutex Health's value of 1.61 is 4.9% above this benchmark. Historically, Nutex Health's own PS Ratio has ranged from 0.09 to 19.91 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 1.54, Nutex Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.54, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current PS Ratio of 1.61 is 4.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nutex Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current PS Ratio is 1.61, which is 77% above median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (NUTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $82.60, compared to a current price of $191.69 — trading 132.1% above its estimated fair value. The current PS Ratio is 1.61, which is 77% above median its 10-year median of 0.91 and 4.9% above the Healthcare Providers & Services industry median of 1.54. Nutex Health's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Nutex Health (NUTX), the current PS Ratio is 1.61 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (NUTX) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of $191.69 is trading 132.1% above its estimated GF Value™ of $82.60.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for NUTX:
PS Ratio: 1.61 (77% above median its 10-year median of 0.91)
GF Value™: $82.60 vs. price of $191.69 (132.1% above fair value)
Industry Position: 4.9% above the Healthcare Providers & Services median (#340 of 662)
No single metric tells the full story. See the NUTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
75GF Score
Get the complete analysis for NUTX
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUTX has been successfully added to your 
